Published • loading... • Updated
Apotex Health Upsizes Initial Public Offering to Sell $1.3 Billion in Shares
Strong investor demand pushed the offering to the top of its marketed range and lifted proceeds about 30% above Apotex’s initial target.
- On Tuesday, Apotex Health Corp. priced its initial public offering at C$24 per share, hitting the top of its expected range and raising C$1.3 billion in Canada's largest IPO since 2021.
- New York-based SK Capital Partners acquired Apotex in 2023, valuing the drug manufacturer between C$3 billion and C$4 billion. Founder Barry Sherman established the company in 1974.
- Apotex sold 35.4 million shares while selling holders divested about 18.8 million shares on Monday. The deal priced at the top of the C$20 to C$24 range, reflecting a 30 per cent increase from original plans.
- Shares will trade on the Toronto Stock Exchange under the symbol APTX. Royal Bank, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Jefferies Financial Group Inc. managed the offering.
- Listings in Canada have slowed significantly since a 2021 peak. Delistings and take-privates have outpaced new offerings, causing the number of public companies to shrink for the fourth consecutive year in 2025.
Insights by Ground AI
15 Articles
15 Articles
Apotex Health prices upsized initial public offering at $24 per share
TORONTO — Drug company Apotex Health Corp. has priced its initial public offering at $24 per share. In its final prospectus, the company says it will issue 54,166,670 shares in the offering that is expected to see gross proceeds total $1.3 billion.
Canadian health firm Apotex prices IPO at top end, raising ...
·New York, United States
Read Full Article
The pharmaceutical company Apotex Health fixes the price of its first public call for savings at $24 per share, while the Toronto Stock Exchange announces that its shares are traded from Wednesday under the symbol APTX.
·Montreal, Canada
Read Full Article
The Toronto Star+4 Reposted by 4 other sources
Apotex Health upsizes initial public offering to sell $1.3 billion in shares
Drug company Apotex Health Corp. is increasing the size of its initial public offering to about $1.3 billion, up from its earlier plan for $1 billion.
·Toronto, Canada
Read Full Article
Coverage Details
Total News Sources15
Leaning Left6Leaning Right2Center3Last UpdatedBias Distribution55% Left
Bias Distribution
- 55% of the sources lean Left
55% Left
L 55%
C 27%
R 18%
Factuality
To view factuality data please Upgrade to Premium
